Aier Healthcare Insurance Joint Venture Launched by Aier Eye Hospital's Controlling Shareholder with Five Listed Companies

VCBeat News: Last night, five listed companies—Talkweb Information System, Yongqing Environmental Protection, Centre Testing International, Leimei Pharmaceutical, and Hunan TV & Broadcast Intermediary—simultaneously announced plans to jointly establish Leimei Pharmaceutical Aier Health Insurance Co., Ltd. with Tibet Aier Medical Investment Co., Ltd.

Aier Health Insurance’s registered capital is proposed to be RMB 1 billion. Among the shareholders, Talkweb Information System, Yongqing Environmental Protection, Centre Testing International Group, Lummy Pharmaceutical, and Hunan TV & Broadcast Intermediary each contribute RMB 160 million in cash, accounting for 16% of Aier Insurance’s registered capital respectively.

Talkweb Information: The establishment of Aier Insurance through this investment will further improve the medical security mechanism for critical and severe illnesses, strengthen the effective coordination between basic medical insurance, urban and rural residents’ critical illness insurance, commercial health insurance, and medical assistance, and enhance the prevention and control of common conditions among students, such as myopia and obesity.

CTI: By entering the insurance business, CTI aims to enhance its synergistic service capabilities with its existing medical and health testing operations, which will help further optimize the company’s investment structure, broaden its business scope, and create new sources of revenue.

Yongqing Environmental Protection: Entering new financial businesses such as health insurance is conducive to optimizing the company's investment structure and enhancing its overall risk resistance capability.

Lai Mei Pharmaceutical: This investment aligns with the company’s strategic direction in healthcare and wellness, will foster synergies with its existing business operations, and is conducive to enhancing its overall competitiveness.

Dian Guang Media: The Company’s cable network business, investment management business, and mobile marketing business can generate synergies with the health insurance business in areas such as customer resources and integrated marketing.

Tibet Aier Medical is the controlling shareholder of Aier Eye Hospital, a publicly listed nationwide chain of ophthalmic medical institutions (stock code: 300015; included in the CSI 300 Index). As of 2016, it had established more than 130 specialized eye hospitals across 27 provinces, municipalities, and autonomous regions in China, covering direct-administered municipalities, provincial capitals, prefecture-level cities, and county towns, with an annual outpatient volume exceeding 4 million visits.